Minyang Jiang, CEO of GoRide, discusses the motor company's nationwide push to grow in the competitive healthcare transportation space.
Thursday, May 30, 2019

'The people that are taking people to healthcare appointments should have healthcare themselves'

Healthcare transportation continues to provide ample opportunities for outside corporate players to innovate the healthcare experience. Now Ford Motor Company, through its GoRide subsidiary, is challenging Lyft and Uber for market share in the increasingly competitive space. I had the chance to speak with Minyang Jiang, CEO of GoRide, about expansion plans and the future of non-emergency medical transportation.

Another reminder: Our 2019 CFO Exchange held at the American Club in Kohler, Wisconsin from August 7 - 9, is getting closer! 

If you're the CFO of a health system and interested in attending, follow the link here for an invitation. 
 
lead story
Ford GoRide CEO on Medical Expansion: 'We're Not Just In It to Move People Around'
Minyang Jiang, CEO of GoRide, discusses the motor company's nationwide push to grow in the competitive healthcare transportation space.
 
 
analysis
Earnings Solid for Health Insurers in Q1 Due to Membership Growth
  • Though stable medical cost trends and membership growth has benefited private insurers, there is an increased political risk going forward.
     
  • The average year-over-year adjusted EBITDA growth for insurers was 29% in Q1 2019.
     
  • Despite the welcome news about the strength of the sector, Moody's warned about the potential integration risks stemming from M&A activity.
     
  • Another key takeaway from Q1 was the ongoing legal battle between Anthem and Cigna over the failed 2017 merger.
analysis
Lawmakers Push To Stop Surprise ER Billing
  • California state lawmakers are trying to close gaps in the law with a bill that would limit how much hospitals outside of a patient's insurance network can charge for emergency care.
     
  • However, health policy experts say the problem demands federal action rather than an inconsistent patchwork of state laws.
analysis
Mass General, 2 NH Hospitals Complete Affiliation Agreement
  • The deal will create a Granite State-based nonprofit entity overseeing Exeter Health Resources and Wentworth-Douglass Hospital under the Massachusetts General Hospital brand.
     
  • A letter of intent was signed by the three organizations last May.
     
  • The next steps of the agreement will be a review process led by state and federal regulators, which the three hospitals believe will take several months.
analysis
Pharmaceutical Spending to Top $370B in 2019
  • U.S. pharmaceutical spending is expected to grow by 2.5% in 2019, topping $370 billion, while overall healthcare spending is projected to grow by 4% and reach $3.6 trillion.
     
  • By 2023, Fitch Solutions estimates pharmaceutical sales will top $420 billion, account for nearly 1.7% of the national GDP, and 9.7% of overall health expenditures.
     
  • The pharmaceutical market forecast is unchanged since the Q2 2019 update, though the overall healthcare market forecast was revised downwards.
analysis
Medicare Advantage Premiums Fall 33% in Q1
  • When zero-dollar premium plans were removed, costs still dropped by 13%, according to a survey from eHealth.
     
  • The health insurance exchange reported a 87% year-over-year increase in the amount of MA and Medicare Part D applications received during the open enrollment period that lasted from January to March.
 
 

Must Reads
 

Final Notes

If you have any tips, story ideas, thoughts, calendar items, press releases, criticisms, corrections, or general advice, send them my way at jobrien@healthleadersmedia.com.

If email isn't your thing, follow me on Twitter at @imjackobrien, (along with the official HealthLeaders account, @HealthLeaders), or connect with me on LinkedIn.

Don't forget to tell your friends and colleagues about our weekly newsletter, they can sign up for free by following this link.

I will see all of you on June 6, for the publication of my first magazine cover story!

That's all, folks.

Jack O'Brien
Finance Editor